SCHEMBL19212992

SCHEMBL19212992

C=C(Oc1ccc(Cl)cc1)C(=O)c1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 4/20 0.56
CES1 P23141 4/20 0.56
CYP11B1 P15538 4/20 0.54
CYP11B2 P19099 4/20 0.54
HPGD P15428 1/20 0.52
ELANE P08246 1/20 0.49
MAPT P10636 1/20 0.47
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HTT P42858 1/20 0.44
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
CA1 P00915 1/20 0.42
CA2 P00918 1/20 0.42
LMNA P02545 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
PTGS2 P35354 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19212944 0.93 HPGD (0.64) CES2CES1CYP11B1CYP11B2HPGD
SCHEMBL8669129 0.91 CES2 (0.58) CES2CES1CYP11B1CYP11B2HPGD
SCHEMBL19212935 0.87 CYP11B1 (0.64) CES2CES1CYP11B1CYP11B2HPGD
SCHEMBL26813754 0.87 CYP11B1 (0.48) CES2CES1CYP11B1CYP11B2HPGD
SCHEMBL19212940 0.86 CYP11B1 (0.64) CYP11B1CYP11B2HPGDELANEMAOB
SCHEMBL13274370 0.80 HPGD (0.46) CYP11B1CYP11B2HPGDELANEMAPT
SCHEMBL8672089 0.78 CES2 (0.58) CES2CES1CYP11B1CYP11B2HPGD
SCHEMBL19212998 0.78 CYP11B1 (0.58) CES2CES1CYP11B1CYP11B2HPGD
SCHEMBL12963563 0.76 CES2 (0.52) CES2CES1ELANEMAPTSMN1; SMN2
SCHEMBL28662701 0.76 CES2 (0.54) CES2CES1CYP11B1CYP11B2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212636-B1 NEW PYRIDINYLOXY- AND PHENYLOXY-PYRAZOLYL COMPOUNDS HOFFMANN LA ROCHE (CH) 2023-11-29 EP disclosed
US-9790217-B2 Pyridinyloxy- and phenyloxy-pyrazolyl compounds HOFFMANN-LA ROCHE INC. (US) 2017-10-17 US disclosed
US-20170226097-A1 PYRIDINYLOXY- AND PHENYLOXY-PYRAZOLYL COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226097-A1 PYRIDINYLOXY- AND PHENYLOXY-PYRAZOLYL COMPOUNDS PDXK, PNPO, PAH CES2 1748/4885CES1 3040/4885CYP11B1 84/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.